Li W - Search Results

1

Association between immune-related adverse events and immunotherapy efficacy in non-small-cell lung cancer: a meta-analysis.

Lin L, Liu Y, Chen C, Wei A, Li W. Lin L, et al. Among authors: li w. Front Pharmacol. 2023 May 22;14:1190001. doi: 10.3389/fphar.2023.1190001. eCollection 2023. Front Pharmacol. 2023. PMID: 37284302 Free PMC article.

2

Peripherally inserted central catheters versus implantable port catheters for cancer patients: a meta-analysis.

Lin L, Li W, Chen C, Wei A, Liu Y. Lin L, et al. Among authors: li w. Front Oncol. 2023 Jul 14;13:1228092. doi: 10.3389/fonc.2023.1228092. eCollection 2023. Front Oncol. 2023. PMID: 37519803 Free PMC article.

3

A meta-analysis of the efficacy of programmed cell death 1/its ligand inhibitors plus cytotoxic T-lymphocyte-associated antigen 4 inhibitors in non-small cell lung cancer.

Lin L, Xiao L, Li L, Chen C, Zhang H, Yu C, Zhang L, Wei A, Li W. Lin L, et al. Among authors: li w, li l. Front Pharmacol. 2024 Feb 5;15:1267763. doi: 10.3389/fphar.2024.1267763. eCollection 2024. Front Pharmacol. 2024. PMID: 38379896 Free PMC article.

4

Development and validation of a prognostic nomogram to predict 30-day all-cause mortality in patients with CRO infection treated with colistin sulfate.

Li W, Liu Y, Xiao L, Cai X, Gao W, Xu D, Han S, He Y. Li W, et al. Front Pharmacol. 2024 Jul 17;15:1409998. doi: 10.3389/fphar.2024.1409998. eCollection 2024. Front Pharmacol. 2024. PMID: 39101134 Free PMC article.

5

Cost-effectiveness analysis of sugemalimab vs. placebo, in combination with chemotherapy, for treatment of first-line metastatic NSCLC in China.

Li W, Wan L. Li W, et al. Front Public Health. 2022 Nov 3;10:1015702. doi: 10.3389/fpubh.2022.1015702. eCollection 2022. Front Public Health. 2022. PMID: 36408023 Free PMC article. Clinical Trial.

6

Current landscape of exosomes in tuberculosis development, diagnosis, and treatment applications.

Sun X, Li W, Zhao L, Fan K, Qin F, Shi L, Gao F, Zheng C. Sun X, et al. Among authors: li w. Front Immunol. 2024 May 23;15:1401867. doi: 10.3389/fimmu.2024.1401867. eCollection 2024. Front Immunol. 2024. PMID: 38846947 Free PMC article. Review.

7

Hypoxia reconstructed colorectal tumor microenvironment weakening anti-tumor immunity: construction of a new prognosis predicting model through transcriptome analysis.

Zhang R, Gao Y, Li C, Tao R, Mao G, Song T, Nie W, Liu S, Tao K, Li W. Zhang R, et al. Among authors: li c, li w. Front Immunol. 2024 Dec 6;15:1425687. doi: 10.3389/fimmu.2024.1425687. eCollection 2024. Front Immunol. 2024. PMID: 39712012 Free PMC article.

8

Community characteristics of autotrophic CO₂-fixing bacteria in karst wetland groundwaters with different nitrogen levels.

Wang X, Li W, Cheng A, Shen T, Xiao Y, Zhu M, Pan X, Yu L. Wang X, et al. Among authors: li w. Front Microbiol. 2022 Aug 15;13:949208. doi: 10.3389/fmicb.2022.949208. eCollection 2022. Front Microbiol. 2022. PMID: 36046022 Free PMC article.

9

Engineered 5-HT producing gut probiotic improves gastrointestinal motility and behavior disorder.

Li B, Li M, Luo Y, Li R, Li W, Liu Z. Li B, et al. Among authors: li w, li m, li r. Front Cell Infect Microbiol. 2022 Oct 20;12:1013952. doi: 10.3389/fcimb.2022.1013952. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36339343 Free PMC article.

10

Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus.

Zhao L, Fan K, Sun X, Li W, Qin F, Shi L, Gao F, Zheng C. Zhao L, et al. Among authors: li w. Front Immunol. 2024 Jan 8;14:1305325. doi: 10.3389/fimmu.2023.1305325. eCollection 2023. Front Immunol. 2024. PMID: 38259491 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81,859 results

Search Page

Filters